(19)
(11) EP 1 432 706 A2

(12)

(88) Date of publication A3:
04.12.2003

(43) Date of publication:
30.06.2004 Bulletin 2004/27

(21) Application number: 02799636.2

(22) Date of filing: 26.09.2002
(51) International Patent Classification (IPC)7: C07D 417/14, C07D 417/04, A61P 35/00
// (C07D277/00, 265:00, 213:00, 333:00)
(86) International application number:
PCT/US2002/030483
(87) International publication number:
WO 2003/027085 (03.04.2003 Gazette 2003/14)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.09.2001 US 324993 P

(71) Applicant: Bayer Pharmaceuticals Corporation
West Haven, CT 06516 (US)

(72) Inventors:
  • BIERER, Donald
    Bethany, CT 06524 (US)
  • MCCLURE, Andrea
    West Haven, CT 06516 (US)
  • FU, Wenlang
    Hamden, CT 06518 (US)
  • ACHEBE, Furahi
    West Haven, CT 06516 (US)
  • LADOUCEUR, Gaetan H.
    Guilford, Connecticut 06437 (US)
  • BURKE, Michael J.
    New Haven, CT 06511 (US)
  • BI, Cheng
    West Haven, CT 06516 (US)
  • HART, Barry
    Palo Alto, California 94301 (US)
  • DUMAS, Jacques
    Bethany, CT 06524 (US)
  • SIBLEY, Robert
    North Haven, CT 06473 (US)
  • SCOTT, William J.
    Guilford, CT 06437 (US)
  • JOHNSON, Jeffrey
    Branford, CT 06405 (US)
  • ASGARI, Davoud
    Newton, Pennsylvania 18940 (US)

(74) Representative: Linkenheil, Dieter 
Bayer HealthCare AG
51368 Leverkusen
51368 Leverkusen (DE)

   


(54) 3-PYRIDYL OR 4-ISOQUINOLINYL THIAZOLES AS C17,20 LYASE INHIBITORS